Efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C

World Journal of Gastroenterology : WJG
Celal AyazMehmet Faruk Geyik

Abstract

To evaluate the efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C. Thirty-six hemodialysis patients with chronic hepatitis C were enrolled in a controlled and prospective study. All patients were treatment naive, positive tested for anti-HCV antibodies, and positive tested for serum HCV-RNA. Twenty-two patients received 135 microg peglyated-interferon alpha-2a weekly for 48 wk (group A). The remaining patients were left untreated, eleven refused therapy, and three were not candidates for kidney transplantation and were allocated to the control group (group B). At the end of the treatment biochemical and virological response was evaluated, and 24 wk after completion of therapy sustained virological response (SVR) was assessed. Side effects were monitored. Of 22 hemodialysis patients, 12 were male and 10 female, with a mean age of 35.2 +/- 12.1 years. Virological end-of-treatment response was observed in 14 patients (82.4%) in group A and in one patient (7.1%) in group B (P = 0.001). Sustained virological response was observed in 11 patients (64.7%) in group A and in one patient in group B (7.1%). Biochemical response parameters normalized in 10/14 patients (71.4%) at the end o...Continue Reading

References

Jul 29, 1995·Lancet·S B JaiswalD S Chitnis
Jul 1, 1993·Journal of Clinical Microbiology·C S HuangC A Tan
Apr 1, 1997·Kidney International·B J Pereira, A S Levey
Dec 12, 1997·The Journal of Infectious Diseases·J IzopetJ Puel
Apr 4, 2000·Journal of Medical Virology·G SalamaJ Izopet
Dec 7, 2000·The New England Journal of Medicine·S ZeuzemM J Brunda
Feb 24, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·A C TanB Vroom
Jun 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fabrizio FabriziPaul Martin
Jul 9, 2002·Seminars in Dialysis·Jerome I TokarsMatthew J Arduino
Jul 15, 2003·Clinical Microbiology Reviews·David K Henderson
Dec 5, 2003·Alimentary Pharmacology & Therapeutics·F FabriziP Martin
Jul 1, 2004·Alimentary Pharmacology & Therapeutics·B E Annicchiarico, M Siciliano
Jul 13, 2004·Journal of Hepatology·Montserrat Garcia-Retortillo, Xavier Forns
May 21, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Kamyar Kalantar-ZadehLoren G Miller
Apr 28, 2006·Journal of Viral Hepatitis·A BruchfeldR Schvarcz
Apr 28, 2006·Journal of Gastroenterology and Hepatology·Omer Faruk KokogluIsmet Onder Isik
Jul 11, 2006·World Journal of Gastroenterology : WJG·Ioan SporeaCorina Vernic
Jul 27, 2006·Digestive Diseases and Sciences·Haldun SelcukSedat Boyacioglu
Dec 1, 1997·Indian Journal of Clinical Biochemistry : IJCB·R BhagwatA Sepaha

❮ Previous
Next ❯

Citations

Apr 14, 2010·Nature Reviews. Nephrology·Fabrizio FabriziPaul Martin
Feb 10, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Adrian CovicUNKNOWN ERA-EDTA ERBP Advisory Board
May 25, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Nassim KamarLionel Rostaing
Jan 26, 2011·Journal of Gastroenterology and Hepatology·Chen-Hua Liu, Jia-Horng Kao
Apr 13, 2011·Seminars in Dialysis·Andres F CarrionPaul Martin
Jan 10, 2012·World Journal of Gastroenterology : WJG·Abdulrahman A AljumahAbdulla A Al Sayyari
May 9, 2014·International Journal of Nanomedicine·Chen-Hua Liu, Jia-Horng Kao
Oct 13, 2014·Transplantation Reviews·Alan Gunderson, Adnan Said
Jul 21, 2012·Clinical and Experimental Nephrology·Şükran KöseGülsün Çavdar
Jul 15, 2011·International Journal of Nephrology·Marco CarboneJames Neuberger
Jul 23, 2015·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Fabrizio FabriziPaul Martin
Jul 5, 2013·Kidney International·Fabrizio FabriziPiergiorgio Messa
Feb 4, 2010·Clinics in Liver Disease·Fabrizio Fabrizi, Paul Martin
Oct 2, 2015·Néphrologie & thérapeutique·Anaïs Vallet-Pichard, Stanislas Pol
Jul 24, 2012·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Takashi AkibaTadao Akizawa
Jul 13, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Chrisoula PipiliEvangelos Cholongitas
Jul 30, 2008·Journal of Hepatology·Paul Martin, Fabrizio Fabrizi
Apr 17, 2015·European Journal of Internal Medicine·Sang Bong AhnJae Il Chung
Aug 12, 2010·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Ayla GokmenHuseyin Engin
Jan 5, 2018·Journal of Gastroenterology·Goki SudaNaoya Sakamoto
Jul 16, 2020·Journal of Gastroenterology and Hepatology·Goki Suda, Naoya Sakamoto
Dec 18, 2014·World Journal of Gastroenterology : WJG·Bruno PozzettoPhilippe Berthelot
Aug 20, 2015·The Cochrane Database of Systematic Reviews·Ravindra A PrabhuDeepak Suvarna
Mar 1, 2013·Hepatology International·Aline Gonzalez Vigani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.